Moreover, high GR expression was a strong predictor of poor prognosis in AR low, AR intermediate and AR high cancers (p < 0.0001 each).<h4>Conclusion</h4>High level expression of GR is strongly linked to prostate cancer aggressiveness in uni- and multivariate analysis. This evidence concerns the gene NR3C1 and prostate carcinoma.